New EU guidance to speed up processing of variations
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has issued guidance on the new EU rules for changes to marketing authorisations which, together with face-to-face dialogue between the company and the agency, is intended to speed up the processing of variation applications.